Baseline characteristics of the study cohort and after stratification into two groups based on the presence of CHF
Variable . | All patients . | Without CHF . | With CHF . |
---|---|---|---|
Number of patients | 172 199 | 117 238 | 54 961 |
Age, years | 62.1 ± 14.8 | 60.9 ± 15.2 | 64.8 ± 13.6 |
Gender, male, % | 55.1 | 55.8 | 53.7 |
Race, White, % | 61.6 | 61.0 | 62.8 |
Diabetic, % | 64.2 | 61.4 | 70.2 |
CHF, % | 31.9 | N/A | N/A |
Central venous catheter as vascular access, % | 29.9 | 29.2 | 31.2 |
Pre-dialysis SBP, mmHg | 149.6 ± 19.3 | 150.0 ± 18.8 | 148.7 ± 20.3 |
Post-dialysis SBP, mmHg | 139.6 ± 17.2 | 139.7 ± 16.9 | 139.3 ± 17.6 |
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg | −10.0 ± 13.9 | −10.4 ± 13.8 | −9.4 ± 14.2 |
UFR, mL/kg/h | 9.1 ± 3.3 | 9.0 ± 3.3 | 9.4 ± 3.3 |
Body mass index, kg/m2 | 28.3 ± 7.6 | 28.2 ± 7.5 | 28.7 ± 7.8 |
Interdialytic weight change, percentage of post-HD weight | 3.3 ± 1.2 | 3.3 ± 1.2 | 3.4 ± 1.2 |
Serum albumin, g/dL | 3.7 ± 0.4 | 3.7 ± 0.4 | 3.7 ± 0.4 |
enPCR, g/kg/day | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 |
Variable . | All patients . | Without CHF . | With CHF . |
---|---|---|---|
Number of patients | 172 199 | 117 238 | 54 961 |
Age, years | 62.1 ± 14.8 | 60.9 ± 15.2 | 64.8 ± 13.6 |
Gender, male, % | 55.1 | 55.8 | 53.7 |
Race, White, % | 61.6 | 61.0 | 62.8 |
Diabetic, % | 64.2 | 61.4 | 70.2 |
CHF, % | 31.9 | N/A | N/A |
Central venous catheter as vascular access, % | 29.9 | 29.2 | 31.2 |
Pre-dialysis SBP, mmHg | 149.6 ± 19.3 | 150.0 ± 18.8 | 148.7 ± 20.3 |
Post-dialysis SBP, mmHg | 139.6 ± 17.2 | 139.7 ± 16.9 | 139.3 ± 17.6 |
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg | −10.0 ± 13.9 | −10.4 ± 13.8 | −9.4 ± 14.2 |
UFR, mL/kg/h | 9.1 ± 3.3 | 9.0 ± 3.3 | 9.4 ± 3.3 |
Body mass index, kg/m2 | 28.3 ± 7.6 | 28.2 ± 7.5 | 28.7 ± 7.8 |
Interdialytic weight change, percentage of post-HD weight | 3.3 ± 1.2 | 3.3 ± 1.2 | 3.4 ± 1.2 |
Serum albumin, g/dL | 3.7 ± 0.4 | 3.7 ± 0.4 | 3.7 ± 0.4 |
enPCR, g/kg/day | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 |
Data are expressed as mean ± SD or percentage.
enPCR, equilibrated normalized protein catabolic rate; N/A, not applicable.
Baseline characteristics of the study cohort and after stratification into two groups based on the presence of CHF
Variable . | All patients . | Without CHF . | With CHF . |
---|---|---|---|
Number of patients | 172 199 | 117 238 | 54 961 |
Age, years | 62.1 ± 14.8 | 60.9 ± 15.2 | 64.8 ± 13.6 |
Gender, male, % | 55.1 | 55.8 | 53.7 |
Race, White, % | 61.6 | 61.0 | 62.8 |
Diabetic, % | 64.2 | 61.4 | 70.2 |
CHF, % | 31.9 | N/A | N/A |
Central venous catheter as vascular access, % | 29.9 | 29.2 | 31.2 |
Pre-dialysis SBP, mmHg | 149.6 ± 19.3 | 150.0 ± 18.8 | 148.7 ± 20.3 |
Post-dialysis SBP, mmHg | 139.6 ± 17.2 | 139.7 ± 16.9 | 139.3 ± 17.6 |
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg | −10.0 ± 13.9 | −10.4 ± 13.8 | −9.4 ± 14.2 |
UFR, mL/kg/h | 9.1 ± 3.3 | 9.0 ± 3.3 | 9.4 ± 3.3 |
Body mass index, kg/m2 | 28.3 ± 7.6 | 28.2 ± 7.5 | 28.7 ± 7.8 |
Interdialytic weight change, percentage of post-HD weight | 3.3 ± 1.2 | 3.3 ± 1.2 | 3.4 ± 1.2 |
Serum albumin, g/dL | 3.7 ± 0.4 | 3.7 ± 0.4 | 3.7 ± 0.4 |
enPCR, g/kg/day | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 |
Variable . | All patients . | Without CHF . | With CHF . |
---|---|---|---|
Number of patients | 172 199 | 117 238 | 54 961 |
Age, years | 62.1 ± 14.8 | 60.9 ± 15.2 | 64.8 ± 13.6 |
Gender, male, % | 55.1 | 55.8 | 53.7 |
Race, White, % | 61.6 | 61.0 | 62.8 |
Diabetic, % | 64.2 | 61.4 | 70.2 |
CHF, % | 31.9 | N/A | N/A |
Central venous catheter as vascular access, % | 29.9 | 29.2 | 31.2 |
Pre-dialysis SBP, mmHg | 149.6 ± 19.3 | 150.0 ± 18.8 | 148.7 ± 20.3 |
Post-dialysis SBP, mmHg | 139.6 ± 17.2 | 139.7 ± 16.9 | 139.3 ± 17.6 |
Peridialytic SBP change (= post-SBP − pre-SBP), mmHg | −10.0 ± 13.9 | −10.4 ± 13.8 | −9.4 ± 14.2 |
UFR, mL/kg/h | 9.1 ± 3.3 | 9.0 ± 3.3 | 9.4 ± 3.3 |
Body mass index, kg/m2 | 28.3 ± 7.6 | 28.2 ± 7.5 | 28.7 ± 7.8 |
Interdialytic weight change, percentage of post-HD weight | 3.3 ± 1.2 | 3.3 ± 1.2 | 3.4 ± 1.2 |
Serum albumin, g/dL | 3.7 ± 0.4 | 3.7 ± 0.4 | 3.7 ± 0.4 |
enPCR, g/kg/day | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.2 |
Data are expressed as mean ± SD or percentage.
enPCR, equilibrated normalized protein catabolic rate; N/A, not applicable.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.